These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25088165)

  • 1. Frequency and determinants of intracranial atherosclerotic stroke in urban Pakistan.
    Kamal AK; Rasheed A; Mehmood K; Murtaza M; Zaidi M; Khan M; Shah N; Samuel M; Ahmed B; Raza E; Ahmed N; Ara J; Ahsan T; Munir SM; Ali S; Maki KU; Ahmed MM; Memon AR; Saleheen D
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2174-2182. PubMed ID: 25088165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population attributable risks of stroke from intracranial atherosclerotic disease (ICAD) in South Asian Pakistanis.
    Kamal AK; Wadiwala MF; Ahmed B; Khan M; Majeed F; Rasheed A;
    Int J Stroke; 2013 Jun; 8(4):E17. PubMed ID: 23692491
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of Systemic Atherosclerosis Burdens and Overlapping Stroke Etiologies and Their Associations With Long-term Vascular Prognosis in Stroke With Intracranial Atherosclerotic Disease.
    Hoshino T; Sissani L; Labreuche J; Ducrocq G; Lavallée PC; Meseguer E; Guidoux C; Cabrejo L; Hobeanu C; Gongora-Rivera F; Touboul PJ; Steg PG; Amarenco P;
    JAMA Neurol; 2018 Feb; 75(2):203-211. PubMed ID: 29279888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-hospital recurrence and functional outcome between ischemic stroke caused by intracranial arterial dissection and intracranial atherosclerosis: Retrospective cohort study of the nationwide multicenter registry.
    Fujiwara G; Oka H; Fujii A
    J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107212. PubMed ID: 37331251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, lifestyle, socioeconomic determinants and rate of asymptomatic intracranial atherosclerosis in stroke free Pakistanis.
    Kamal AK; Majeed F; Pasha O; Rehman H; Islam M; Azam I; Ilyas MS; Hussain M; Masood K; Ahmed B; Nazir S; Sajjad Z; Kasner SE
    BMC Neurol; 2014 Aug; 14():155. PubMed ID: 25124284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial Differences in Prevalence and Risk for Intracranial Atherosclerosis in a US Community-Based Population.
    Qiao Y; Suri FK; Zhang Y; Liu L; Gottesman R; Alonso A; Guallar E; Wasserman BA
    JAMA Cardiol; 2017 Dec; 2(12):1341-1348. PubMed ID: 29094154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
    O'Donnell MJ; Chin SL; Rangarajan S; Xavier D; Liu L; Zhang H; Rao-Melacini P; Zhang X; Pais P; Agapay S; Lopez-Jaramillo P; Damasceno A; Langhorne P; McQueen MJ; Rosengren A; Dehghan M; Hankey GJ; Dans AL; Elsayed A; Avezum A; Mondo C; Diener HC; Ryglewicz D; Czlonkowska A; Pogosova N; Weimar C; Iqbal R; Diaz R; Yusoff K; Yusufali A; Oguz A; Wang X; Penaherrera E; Lanas F; Ogah OS; Ogunniyi A; Iversen HK; Malaga G; Rumboldt Z; Oveisgharan S; Al Hussain F; Magazi D; Nilanont Y; Ferguson J; Pare G; Yusuf S;
    Lancet; 2016 Aug; 388(10046):761-75. PubMed ID: 27431356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease.
    Hoh BL; Gong Y; McDonough CW; Waters MF; Royster AJ; Sheehan TO; Burkley B; Langaee TY; Mocco J; Zuckerman SL; Mummareddy N; Stephens ML; Ingram C; Shaffer CM; Denny JC; Brilliant MH; Kitchner TE; Linneman JG; Roden DM; Johnson JA
    J Neurosurg; 2016 Jun; 124(6):1746-51. PubMed ID: 26587656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and clinical outcomes associated with intracranial and extracranial atherosclerotic stenosis acute ischemic stroke.
    Lei C; Wu B; Liu M; Chen Y
    J Stroke Cerebrovasc Dis; 2014; 23(5):1112-7. PubMed ID: 24189455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased levels of angiogenic growth factors in intracranial atherosclerotic disease despite severity-related increase in endothelial progenitor cell counts.
    Massot A; Navarro-Sobrino M; Penalba A; Arenillas JF; Giralt D; Ribó M; Molina CA; Alvarez-Sabín J; Montaner J; Rosell A
    Cerebrovasc Dis; 2013; 35(1):81-8. PubMed ID: 23429001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Correlates of Intracranial Atherosclerotic Disease Among Community-Dwelling Older Adults of Amerindian Ancestry. The Three Villages Study.
    Del Brutto OH; Del Brutto VJ; Mera RM; Pérez P; Recalde BY; Costa AF; Romano JG; Sedler MJ
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105135. PubMed ID: 32912521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of short-term outcomes between patients with extracranial carotid and/or intracranial atherosclerotic disease.
    Tan BY; Zheng Y; Lim MJR; Koh YY; Tan YK; Goh C; Myint MZ; Sia CH; Tan J; Nor FEM; Soon B; Chan BP; Leow AS; Ho JS; Yeo LL; Sharma VK
    Clin Neurol Neurosurg; 2023 Dec; 235():108024. PubMed ID: 37922680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial Large and Medium Artery Atherosclerotic Disease and Stroke.
    Al Kasab S; Derdeyn CP; Guerrero WR; Limaye K; Shaban A; Adams HP
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1723-1732. PubMed ID: 29602616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological signatures of asymptomatic extra- and intracranial atherosclerosis: the Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study.
    López-Cancio E; Galán A; Dorado L; Jiménez M; Hernández M; Millán M; Reverté S; Suñol A; Barallat J; Massuet A; Alzamora MT; Dávalos A; Arenillas JF
    Stroke; 2012 Oct; 43(10):2712-9. PubMed ID: 22798326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence and prognosis of asymptomatic intracranial atherosclerosis in a community-based population: Results based on high-resolution magnetic resonance imaging.
    Li S; Tang M; Zhang D; Han F; Zhou L; Yao M; Li M; Cui L; Zhang S; Peng B; Jin Z; Zhu Y; Ni J
    Eur J Neurol; 2023 Dec; 30(12):3761-3771. PubMed ID: 37738517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after ischemic stroke caused by intracranial atherosclerosis vs dissection.
    Shin J; Chung JW; Park MS; Lee H; Cha J; Seo WK; Kim GM; Bang OY
    Neurology; 2018 Nov; 91(19):e1751-e1759. PubMed ID: 30291187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2023 Taiwan Stroke Society Guidelines for the management of patients with intracranial atherosclerotic disease.
    Lin CJ; Chung CP; Liao NC; Chen PL; Chi NF; Lai YJ; Tang CW; Wu CH; Chang FC; Luo CB; Fay LY; Lin CF; Chou CH; Lee TH; Lee JT; Jeng JS; Lee IH;
    J Chin Med Assoc; 2023 Aug; 86(8):697-714. PubMed ID: 37341526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of cigarette smoking with intracranial atherosclerosis in the patients with acute ischemic stroke.
    Kim DE; Lee KB; Jang IM; Roh H; Ahn MY; Lee J
    Clin Neurol Neurosurg; 2012 Nov; 114(9):1243-7. PubMed ID: 22445616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging and clinical predictors of unfavorable outcome in medically treated symptomatic intracranial atherosclerotic disease.
    Kate M; Sylaja PN; Kesavadas C; Thomas B
    J Stroke Cerebrovasc Dis; 2014; 23(5):973-8. PubMed ID: 24119624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, diagnosis and management of intracranial atherosclerotic disease.
    Jeng JS; Tang SC; Liu HM
    Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1423-32. PubMed ID: 20936929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.